Nettacin Viscoso (Netilmicin Sulfate)

Netilmicin sulfate, the active ingredient in Nettacin Viscoso, is an aminoglycoside antibiotic presented as a sterile ophthalmic solution for ocular (topical) use. It treats bacterial eye infections in patients requiring local therapy.

GNH USA supplies Nettacin Viscoso as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Netilmicin sulfate is employed to manage bacterial infections of the eye and related ocular tissues.

Conjunctivitis: reduces bacterial load and accelerates resolution of acute bacterial conjunctivitis. Keratitis: eradicates causative organisms in bacterial keratitis and supports corneal healing. Blepharitis: diminishes bacterial colonisation on eyelid margins, improving symptoms. Post‑operative prophylaxis: prevents postoperative ocular infections after cataract or refractive surgery.

Adverse reactions are generally limited to the treated eye, but monitoring is advised.

Common Side Effects: - Ocular irritation or stinging on instillation. - Burning sensation after application. - Redness of the conjunctiva. - Increased tearing.

Serious or Rare Side Effects: - Allergic reaction including anaphylaxis. - Corneal ulceration or epithelial defect. - Severe eye pain indicating possible toxicity.

Before using Nettacin Viscoso, consider the following safety measures. - Assess bacterial susceptibility: confirm that the pathogen is likely responsive to aminoglycosides. - Hypersensitivity: avoid in patients with known allergy to netilmicin or other aminoglycosides. - Renal function: monitor if systemic absorption is suspected, especially in compromised patients. - Contact lens wearers: advise removal of lenses before and after instillation. - Ocular surface integrity: do not use on severely damaged corneas without specialist advice. - Store at room temperature: keep in original container, protect from moisture and light.

Netilmicin may interact with other ophthalmic or systemic agents; awareness helps prevent reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Concurrent use with other aminoglycoside eye drops (e.g., gentamicin) may increase local toxicity. - Simultaneous administration of multiple topical antibiotics can lead to antagonistic effects.

Moderate Interactions (Monitor Closely): - Co‑administration with topical corticosteroids may mask infection signs. - Use with preservative‑containing contact lens solutions may irritate the ocular surface. - Systemic aminoglycosides given concurrently could raise systemic exposure.